Dr Rachel de las Heras: Ledger

Stories naming Dr Rachel de las Heras. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.

Role	Organisation	Sources
Chief Executive Officer and Managing Director	Ceretas	Dealroom, Startup Daily

2 deals

Ceretas triggers final $490,000 grant tranche as dementia device prototypes clear review

Australian medtech Ceretas hit a milestone in its CUREator+ program, unlocking the final instalment of a government-funded grant; the piece also recaps its A$8 million IPO and ASX listing earlier in 2026.

Dealroom Wed 16 Sep 2026 Ceretas ANDHealth Dementia Australia Planet Innovation Queensland Brain Institute University of Queensland Brandon BioCatalyst Medical Research Future Fund Dr Rachel de las Heras

Dr Rachel de las Heras

Roles

Coverage

Ceretas triggers final $490,000 grant tranche as dementia device prototypes clear review